On April 17, 2025, Bristol received approval for a new drug application (NDA 220073), a development that is poised to reshape the competitive landscap...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
CMG PHARM CO LTD announced that its generic New Drug Application (NDA 211448) for [Insert Substance Name] was approved by the FDA on April 15, 2025, a...
# FDA Approves Generic Imatinib Mesylate Camber Pharmaceuticals, Inc. has received FDA approval for its generic formulation of imatinib mesylate, an ...
BIONPHARMA INC. announced the U.S. approval of generic metformin hydrochloride oral solution (ANDA 219151), a move that is expected to bolster supply ...
Fresenius Kabi USA announced on March 14, 2025, the FDA approval of its biosimilar TOCILIZUMAB (TYENNE), a fully human monoclonal antibody for injecti...
# FDA Approves Scienture LLC's ARBLI (Losartan Potassium) for Oral Use The U.S. Food and Drug Administration has approved Scienture LLC's ARBLI (losa...
Camber Pharmaceuticals has received FDA approval for its generic Metformin HCl for oral administration, potentially generating additional revenue thro...
Encube Ethicals, Inc. announced on Tuesday, March 5th, that its generic estradiol topical gel has received FDA approval under application ANDA218507, ...
# FDA Approves BIOCON PHARMA's Generic Lenalidomide, Expanding Access to Key Multiple Myeloma Treatment BIOCON PHARMA INC. has received FDA approval ...
GENENTECH INC has received FDA approval for the drug indicated by NDA219285 on February 11, 2025, a decision that is expected to bolster the company's...
Slate Run Pharmaceuticals has been granted FDA approval for its intravenous gadoteridol injection, granting the company access to the commercial marke...
Gland Pharma Limited announced on Wednesday the FDA approval of its epinephrine injection for intramuscular use, API ANDA219239. This authorization ex...
# FDA Approves Generic Bosentan; Lupin Pharmaceuticals Enters Pulmonary Hypertension Market Lupin Pharmaceuticals, Inc. has received FDA approval for...
Supernus Pharmaceuticals, Inc. announced the FDA approval of ONAPGO (apomorphine hydrochloride) for subcutaneous administration, a launch expected to ...
Macleods Pharmaceuticals Limited obtained FDA approval for its generic Tramadol Hydrochloride oral tablets (ANDA209404), a milestone likely to drive r...
Granules Pharmaceuticals Inc. received FDA approval on January 29 for its New Drug Application for lisdexexamfetamine dimethylate to market the generi...
On January 24, 2025, CELLTRION INC received FDA approval for the new product, a development that underscores the company's strong pipeline and is expe...
Rising Pharma Holdings, Inc. received FDA approval Monday to market its generic version of the antihypertensive and diuretic Spirionolactone (ANDA2194...
# FDA Approves Daiichi Sankyo's DATROWAY (datopotamab deruxtecan) for Oncology Treatment Daiichi Sankyo Inc. received FDA approval for DATROWAY (dato...
Yichang Humanwell announced the FDA’s approval of NDA ANDA219072 on January 16, setting the stage for a new market entrant and driving shareholder val...